B‐cell antigen D8/17 is a marker of rheumatic fever susceptibility in Aboriginal Australians and can be tested in remote settings
- 15 May 2006
- journal article
- research article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 184 (10) , 507-510
- https://doi.org/10.5694/j.1326-5377.2006.tb00345.x
Abstract
Objective: To test the B‐cell antigen D8/17 as a marker of past rheumatic fever (RF) in a predominantly Aboriginal Australian population, and to evaluate technical modifications to allow its use in r...Keywords
This publication has 14 references indexed in Scilit:
- Presence of the d8/17 B‐cell marker in children with rheumatic fever in IsraelClinical Genetics, 2002
- HLA Class II Associations With Rheumatic Heart Disease Are More Evident and Consistent Among Clinically Homogeneous PatientsCirculation, 1999
- Ethnic differences in expression of susceptibility marker(s) in rheumatic fever/rheumatic heart disease patientsInternational Journal of Cardiology, 1998
- HLA class II antigens in rheumatic fever Analysis of the DR locus by restriction fragment-length polymorphism and oligotypingHuman Immunology, 1994
- Frequency of D8/17 B lymphocyte alloantigen in North Indian patients with rheumatic heart diseaseImmunology & Cell Biology, 1992
- Comprehensive Review of Morbidity and Mortality Trends for Rheumatic Fever, Streptococcal Disease, and Scarlet Fever: The Decline of Rheumatic FeverClinical Infectious Diseases, 1989
- HLA-DR/DQ antigens and reactivity to B cell alloantigen D8/17 in Indian patients with rheumatic heart disease.Circulation, 1989
- Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody.Journal of Clinical Investigation, 1989
- Rheumatic fever in childrenAmerican Heart Journal, 1980
- Heredity, infection and chemoprophylaxis in rheumatic carditis: an epidemiological study of a communal settlementEpidemiology and Infection, 1960